NC
Nexthera Capital Portfolio holdings
AUM
$120M
This Quarter Return
+26.26%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$128M
AUM Growth
+$128M
(+11%)
Cap. Flow
+$1.48M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
67.56%
Holding
47
New
10
Increased
10
Reduced
9
Closed
14
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$4.33M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$4.3M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$4.11M |
| 4 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$3.82M |
| 5 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$3.35M |
Top Sells
| 1 |
Viatris
VTRS
|
$6.05M |
| 2 |
GSK
GSK
|
$5.39M |
| 3 |
Amgen
AMGN
|
$4.57M |
| 4 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$4.09M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$2.27M |
Sector Composition
| 1 | Healthcare | 88.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$141B
| $22.2M | 13.61% | 654,051 +27,613 | +4% | +$935K |
|
|
2
GSK
GSK
$79.9B
| $14.9M | 9.14% | 345,000 -125,000 | -27% | -$5.39M |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $13M | 7.98% | 67,000 -7,000 | -9% | -$1.36M |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.88M | 4.84% | 217,817 +118,817 | +120% | +$4.3M |
|
|
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.02M | 3.7% | 111,500 -40,000 | -26% | -$2.16M |
|
6
Insmed
INSM
$28.8B
| $4.68M | 2.87% | 322,044 +153,344 | +91% | +$2.23M |
|
|
ADMS
7
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.57M | 2.81% | 278,740 +100,500 | +56% | +$1.65M |
|
8
Neurogene
NGNE
$264M
| $4.54M | 2.79% | 340,000 -158,300 | -32% | -$2.11M |
|
|
LCI
9
DELISTED
Lannett Company, Inc.
LCI
| $4.44M | 2.73% | 167,000 -63,000 | -27% | -$1.67M |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.33M | 2.66% | +120,000 | New | +$4.33M |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $4.11M | 2.52% | +1,263,276 | New | +$4.11M |
|
|
CLCD
12
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $3.82M | 2.34% | +100,000 | New | +$3.82M |
|
|
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.54M | 2.17% | 264,000 +250,000 | +1,786% | +$3.35M |
|
|
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
| $2.97M | 1.83% | +260,000 | New | +$2.97M |
|
15
Ascendis Pharma
ASND
$11.8B
| $2.94M | 1.81% | +146,200 | New | +$2.94M |
|
16
FibroGen
FGEN
$47.8M
| $2.64M | 1.62% | 127,680 -26,320 | -17% | -$545K |
|
|
NDRM
17
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.42M | 1.49% | +131,000 | New | +$2.42M |
|
|
IMDZ
18
DELISTED
Immune Design Corp.
IMDZ
| $2.31M | 1.42% | 305,000 +219,862 | +258% | +$1.67M |
|
|
PGNX
19
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.22M | 1.36% | 350,000 +254,000 | +265% | +$1.61M |
|
|
ADXS
20
DELISTED
Advaxis, Inc.
ADXS
| $2.14M | 1.31% | 200,000 +75,000 | +60% | +$802K |
|
|
TRVN
21
DELISTED
Trevena, Inc.
TRVN
| $2.02M | 1.24% | 298,849 +148,849 | +99% | +$1M |
|
22
Abeona Therapeutics
ABEO
$350M
| $1.93M | 1.19% | 321,609 +221,609 | +222% | +$1.33M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.89M | 1.16% | 50,000 -60,280 | -55% | -$2.27M |
|
|
CNCE
24
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.7M | 1.04% | 167,866 -15,134 | -8% | -$153K |
|
|
SIOX
25
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.4M | 0.86% | +100,000 | New | +$1.4M |
|